XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.0.1
Consolidated Statements of Loss - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]      
Net sales $ 1,666.2 $ 1,832.8 $ 1,947.6
Cost of products sold 1,110.8 1,234.5 1,395.3
Gross profit 555.4 598.3 552.3
Operating costs and expenses:      
Selling, general and administrative expenses 365.7 393.5 376.7
Amortization of intangibles 44.7 43.4 41.5
Restructuring 16.8 27.2 9.6
Impairment of goodwill and intangible assets 165.2 89.5 98.7
Change in fair value of contingent consideration 0.0 0.0 (9.0)
Total operating costs and expenses 592.4 553.6 517.5
Operating (loss) income (37.0) 44.7 34.8
Non-operating expense (income):      
Interest expense 52.6 58.6 45.6
Interest income (7.5) (7.1) (8.3)
Non-operating pension expense (income) 6.1 1.8 (4.5)
Other (income) expense, net (0.9) 4.5 (12.9)
(Loss) income before income tax (87.3) (13.1) 14.9
Income tax expense 14.3 8.7 28.1
Net loss $ (101.6) $ (21.8) $ (13.2)
Per share:      
Basic loss per share $ (1.06) $ (0.23) $ (0.14)
Diluted loss per share $ (1.06) $ (0.23) $ (0.14)
Weighted average number of shares outstanding:      
Basic (in shares) 95.6 95.3 95.3
Diluted (in shares) [1] 95.6 95.3 95.3
[1] Due to the net loss during the twelve months ended December 31, 2024, 2023 and 2022, diluted earnings per share are the same as basic earnings per share.